Our senior management team comprises leaders with significant industry experience and passion for our mission to be a global leader in test-consolidated third party quality control materials and real time peer review software solutions to meet the QC demands and requirements of the modern clinical laboratory. We have a track recording of delivering on our goals and a commitment to our mission.
Co-Founder and Chief Executive Officer
Malcolm co-founded the Company in 2004 and was appointed CEO in 2011. He has successfully co-founded, developed and exited a number of life science and healthcare businesses based on novel technology and drawing on his over 20 years’ experience in these sectors. Malcolm brings extensive sales experience to the Company based on his strong scientific background. Malcolm leads the executive management team and business development activities of the Company while ensuring the business maintains its entrepreneurial and innovative focus. Previously, Malcolm was the co-founder and Joint Managing Director of Technopath (Distribution) which is now part of the Diploma plc group. Malcolm was educated at the National University of Ireland and holds a B.Sc. honours degree in Molecular Biology and a Master's Degree in Biotechnology.
Co-Founder and Chief Scientific Officer
Shane holds a Bachelor of Science in Biochemistry with a minor in Philosophy and Technical Writing from California State University, Fullerton. He began his career with Ortho Diagnostics in 1981 where he worked with a group that developed Uniqual, one of the first stable liquid quality control materials. He joined Bio-Rad in 1992 and served as Principal Scientist until he co-founded Technopath Clinical Diagnostics and developed the Multichem line of liquid, consolidated QC materials.
CEO, Technopath Clinical Diagnostics USA Inc.
Todd joined the Company in 2017 bringing many years of in-vitro diagnostics sales, marketing, product development and management experience. For more than twenty years he was with Bio-Rad Laboratories in many different roles including the Director of Diagnostics Sales for the United States. Todd joins us directly from Mettler-Toledo, LLC where he served as the General Manager of U.S. Laboratory Business. Todd holds a Bachelor of Science degree in Biology with a minor in Chemistry from Stephen F. Austin State University and completed advanced business management studies at the University of California, Berkeley.
Chief Financial Officer
Peter joined the Company in 2014. He brings significant experience to the Company in the areas of finance, corporate development, M&A and financing in both public and private life science companies. He most recently served as SVP Business Integration for Alkermes plc, SVP, Corporate and Business Development for Elan Drug Technologies and CFO of Agenus Inc., a NASDAQ-listed biotechnology company. Peter has served as a Non-Executive Director of both public and private companies including Merrion Pharmaceuticals plc, Cydex Pharmaceuticals Inc. and Agenus Inc. Peter worked at KPMG for 7 years in Ireland and France and is a fellow of Chartered Accountants Ireland. He holds a Bachelor of Commerce degree from University College Cork, Ireland.
Jim O’ Connell
Chief Operations Officer
Jim joined the Company in 2014. Jim brings significant experience in the Medical Device sector in leadership roles in the Operations and HR areas. He was an Operations Manager and HR Leader with Stryker Orthopaedics for 10 years, Business Unit Manager with Schneider Electric and held a number of Operations roles for companies such as 3Com, Intel, Seagate and Microsoft. He holds a BA, Graduate Diploma in Applied Computing and MBA from the University of Limerick.
Head of Quality and Regulatory Affairs
Bernd joined the Company in 2014. Bernd brings significant experience to the company in the area of Global Quality Compliance, GMP and technical expertise in the area of clinical diagnostics and biotechnology. Bernd held a number of positions of increasing responsibility over 11 years at Abbott Diagnostics in Ireland and Germany in the areas of Global Auditing, Technical Support, Validation and Operations. Prior to Abbott Diagnostics, Bernd was Lead Biotechnologist at Strathmann Biotec AG in Germany and R&D Lab Analyst for the DANISCO Cultor Group, Germany. Bernd attended Fresenius University in Idstein, Germany and received his Master’s in Chemical Engineering.
Director of Corporate Development
Michael joined the Company in 2015 and oversees new business developments, contract negotiations, funding negotiations and joint ventures. He also manages internal governance and regulatory compliance for the board of directors as well as the company’s intellectual property interests. Prior to joining Technopath, Michael worked in commercial law practices in Limerick and Dublin. He is a member of the Law Society in both Ireland and England & Wales and was appointed as a Notary Public in 2013. Prior to law school, Michael worked in the European Commission and also the European Parliament in Brussels. Michael carried out his studies at University College Galway and KU Leuven in Belgium and holds a Bachelor of Arts degree and Bachelor of Laws degree.
Director of Informatics
Yuriy joined the Company in 2015. Yuriy successfully founded and developed LAQC Systems, Inc., a Canadian technology company with a primary focus on Quality Control/Quality Assurance data management in the clinical diagnostics laboratory market. He is the architect and developer of all LAQC software products, which have been successfully commercialised on a global basis directly or through partners. Yuriy has pioneered a new business model around QC/QA data management. He brings significant experience to the Company in the areas of software development and the clinical diagnostics laboratory market. Yuriy holds a B.Sc. Honours degree in Applied Mathematics and a Master’s Degree (Honours) in Computer Science.